Blueprint Genetics, NICER Consortium Developing Genetic Test for Immunologic, Hematologic Disorders

Apr 20, 2020

|

NEW YORK – Blueprint Genetics and the North American Immuno-Hematology Clinical Education and Research (NICER) Consortium announced Monday a collaboration on a diagnostic test for patients with immunologic and hematologic disorders.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Blueprint Genetics, NICER Consortium Developing Genetic Test for Immunologic, Hematologic Disorders

To read the full story....

Breaking News

FDA Issues Emergency Use Authorization for University of Nebraska Medical Center Coronavirus Test

Oxford Immunotec Shares Rise Sharply on Report of $400M Acquisition Offer

Medix Biochemica Acquires US Firms EastCoast Bio, Biostride

HHS Releases Data Reporting Guidance for Labs Performing SARS-CoV-2 Testing

Opti Medical Systems Gets CE Mark for Coronavirus Test Kit

AACC Revises Guidance on Management of Point-of-Care Testing

Featured White Papers

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

What's Popular?

Labs Launching Employer SARS-CoV-2 Testing Programs as Businesses Reopen

Beset by COVID-19 Pandemic, Europe Searches for Right Test Mix for Diagnosis, Surveillance

At-Home Coronavirus Tests Get Nod From FDA But Agency Proceeding With Caution

CDC Develops Test for Simultaneous Detection of COVID-19, Flu

HHS Releases Data Reporting Guidance for Labs Performing SARS-CoV-2 Testing

Sponsorships